Clinical Trials Directory

Trials / Completed

CompletedNCT04343638

Effect of Intraoperative Nociception Control Based on Analgesia Nociception Index (ANI) Monitoring on Stress Response During Total Laparoscopic Hysterectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
Female
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The "Analgesia Nociception Index" (ANI; MetroDoloris Medical Systems, Lille, France), derived from an electrocardiogram (ECG) trace, has been proposed as a noninvasive guide to analgesia. The ANI monitor calculates HR variation with respiration, a response mediated primarily by changes in the parasympathetic nervous system (PNS) stimulation to the sinoatrial node of the heart. The aim of this study is to determine the relation between ANI monitor values and serum catecholamine levels. We will compare the serum catecholamine (norepinephrine, epinephrine) levels of conventional nociception control group and ANI-monitor guided nociception control group at the end of surgery.

Conditions

Interventions

TypeNameDescription
DEVICEconventional nociception controlWhile Intraoperative opioid will be administered by conventional clinical practice in control arm.
DEVICEANI monitor guided nociception controlThe intraoperative opioid will be administered by maintaining the 4-minute moving average of ANI ≥50 in ANI-monitor guided nociception control arm.

Timeline

Start date
2020-05-08
Primary completion
2021-10-28
Completion
2021-10-28
First posted
2020-04-13
Last updated
2021-12-29

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04343638. Inclusion in this directory is not an endorsement.